HK Stock MarketDetailed Quotes

00455 TIANDA PHARMA

Watchlist
  • 0.195
  • -0.007-3.47%
Market Closed Oct 10 16:08 CST
419.26MMarket Cap-8863P/E (TTM)

TIANDA PHARMA Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Sep 30, 2022
(FY)Mar 31, 2021
(Q6)Sep 30, 2020
(FY)Mar 31, 2020
(Q6)Sep 30, 2019
(FY)Mar 31, 2019
Turnover
-48.57%156.07M
29.77%532.09M
21.46%303.48M
-13.56%410.02M
--249.86M
-3.49%474.33M
-28.56%187.36M
-6.74%491.48M
-1.38%262.25M
45.76%527M
Operating income
-48.57%156.07M
29.77%532.09M
21.46%303.48M
-13.56%410.02M
249.86M
-3.49%474.33M
-28.56%187.36M
-6.74%491.48M
-1.38%262.25M
45.76%527M
Cost of sales
45.93%-80.23M
-24.92%-276.56M
-16.23%-148.39M
-2.80%-221.38M
---127.67M
-65.06%-215.34M
-12.10%-63.05M
-26.76%-130.46M
-13.27%-56.25M
-12.86%-102.92M
Operating expenses
45.93%-80.23M
-24.92%-276.56M
-16.23%-148.39M
-2.80%-221.38M
-127.67M
-65.06%-215.34M
-12.10%-63.05M
-26.76%-130.46M
-13.27%-56.25M
-12.86%-102.92M
Gross profit
-51.10%75.85M
35.46%255.53M
26.93%155.1M
-27.16%188.64M
122.19M
-28.26%258.99M
-39.66%124.31M
-14.87%361.01M
-4.74%206M
56.86%424.08M
Selling expenses
52.67%-52.72M
-23.80%-186.46M
-20.13%-111.37M
28.87%-150.61M
---92.72M
24.98%-211.73M
36.48%-103.77M
18.12%-282.23M
8.22%-163.37M
-74.80%-344.67M
Administrative expenses
-1.22%-42.51M
-33.79%-84.99M
-1.41%-41.99M
8.97%-63.53M
---41.41M
-2.93%-69.79M
3.29%-34.86M
-7.19%-67.81M
-14.98%-36.05M
-14.88%-63.26M
Research and development expenses
18.45%-7.09M
51.66%-13.11M
27.55%-8.69M
-129.26%-27.11M
---12M
-686.34%-11.83M
-1,508.62%-7.31M
78.25%-1.5M
---454.59K
-120.34%-6.92M
Special items of operating profit
-4.42%3.7M
-15.22%8.28M
-44.88%3.87M
30.31%9.76M
--7.02M
9.66%7.49M
-29.79%4.04M
-59.66%6.83M
-29.44%5.76M
13.13%16.93M
Operating profit
-636.08%-22.77M
51.58%-20.75M
81.71%-3.09M
-59.45%-42.85M
-16.92M
-264.84%-26.87M
-248.02%-17.59M
-37.70%16.3M
-21.09%11.89M
-12.61%26.17M
Financing cost
1.74%-2.43M
1.92%-4.95M
24.56%-2.48M
-785.75%-5.04M
---3.28M
-52.26%-569.35K
13.43%-149.16K
---373.94K
---172.3K
----
Earning before tax
-352.50%-25.2M
46.35%-25.69M
72.43%-5.57M
-74.52%-47.89M
-20.2M
-272.29%-27.44M
-251.47%-17.74M
-39.13%15.93M
-22.23%11.71M
-12.61%26.17M
Tax
-407.75%-2.03M
-81.11%689K
-38.68%658K
139.34%3.65M
--1.07M
121.38%1.52M
148.93%2.15M
30.01%-7.13M
17.08%-4.4M
-30.90%-10.18M
After-tax profit from continuing operations
-454.37%-27.23M
43.48%-25.01M
74.32%-4.91M
-70.71%-44.24M
-19.12M
-394.51%-25.92M
-313.08%-15.59M
-44.94%8.8M
-25.03%7.32M
-27.88%15.98M
Earning after tax
-454.37%-27.23M
43.48%-25.01M
74.32%-4.91M
-70.71%-44.24M
-19.12M
-394.51%-25.92M
-313.08%-15.59M
-44.94%8.8M
-25.03%7.32M
-27.88%15.98M
Minority profit
101.40%11K
73.97%-850K
71.75%-784K
-366.77%-3.27M
---2.78M
-78.36%1.22M
-100.84%-39.78K
-57.55%5.66M
-35.09%4.71M
9.64%13.33M
Profit attributable to shareholders
-559.95%-27.24M
41.05%-24.16M
74.76%-4.13M
-50.97%-40.98M
-16.35M
-963.57%-27.14M
-696.80%-15.55M
18.28%3.14M
4.16%2.61M
-73.45%2.66M
Basic earnings per share
-568.42%-0.0127
41.36%-0.0112
75.00%-0.0019
-51.59%-0.0191
-0.0076
-940.00%-0.0126
-700.00%-0.0072
25.00%0.0015
0.00%0.0012
-74.47%0.0012
Diluted earnings per share
-568.42%-0.0127
41.36%-0.0112
75.00%-0.0019
-51.59%-0.0191
-0.0076
-940.00%-0.0126
-700.00%-0.0072
25.00%0.0015
0.00%0.0012
-74.47%0.0012
Currency Unit
HKD
HKD
HKD
HKD
HKD
HKD
HKD
HKD
HKD
HKD
Accounting Standards
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
Audit Opinions
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
Auditor
--
Ernst & Young
--
Ernst & Young
--
Ernst & Young
--
Ernst & Young
--
Ernst & Young
(Q6)Jun 30, 2024(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Sep 30, 2022(FY)Mar 31, 2021(Q6)Sep 30, 2020(FY)Mar 31, 2020(Q6)Sep 30, 2019(FY)Mar 31, 2019
Turnover -48.57%156.07M29.77%532.09M21.46%303.48M-13.56%410.02M--249.86M-3.49%474.33M-28.56%187.36M-6.74%491.48M-1.38%262.25M45.76%527M
Operating income -48.57%156.07M29.77%532.09M21.46%303.48M-13.56%410.02M249.86M-3.49%474.33M-28.56%187.36M-6.74%491.48M-1.38%262.25M45.76%527M
Cost of sales 45.93%-80.23M-24.92%-276.56M-16.23%-148.39M-2.80%-221.38M---127.67M-65.06%-215.34M-12.10%-63.05M-26.76%-130.46M-13.27%-56.25M-12.86%-102.92M
Operating expenses 45.93%-80.23M-24.92%-276.56M-16.23%-148.39M-2.80%-221.38M-127.67M-65.06%-215.34M-12.10%-63.05M-26.76%-130.46M-13.27%-56.25M-12.86%-102.92M
Gross profit -51.10%75.85M35.46%255.53M26.93%155.1M-27.16%188.64M122.19M-28.26%258.99M-39.66%124.31M-14.87%361.01M-4.74%206M56.86%424.08M
Selling expenses 52.67%-52.72M-23.80%-186.46M-20.13%-111.37M28.87%-150.61M---92.72M24.98%-211.73M36.48%-103.77M18.12%-282.23M8.22%-163.37M-74.80%-344.67M
Administrative expenses -1.22%-42.51M-33.79%-84.99M-1.41%-41.99M8.97%-63.53M---41.41M-2.93%-69.79M3.29%-34.86M-7.19%-67.81M-14.98%-36.05M-14.88%-63.26M
Research and development expenses 18.45%-7.09M51.66%-13.11M27.55%-8.69M-129.26%-27.11M---12M-686.34%-11.83M-1,508.62%-7.31M78.25%-1.5M---454.59K-120.34%-6.92M
Special items of operating profit -4.42%3.7M-15.22%8.28M-44.88%3.87M30.31%9.76M--7.02M9.66%7.49M-29.79%4.04M-59.66%6.83M-29.44%5.76M13.13%16.93M
Operating profit -636.08%-22.77M51.58%-20.75M81.71%-3.09M-59.45%-42.85M-16.92M-264.84%-26.87M-248.02%-17.59M-37.70%16.3M-21.09%11.89M-12.61%26.17M
Financing cost 1.74%-2.43M1.92%-4.95M24.56%-2.48M-785.75%-5.04M---3.28M-52.26%-569.35K13.43%-149.16K---373.94K---172.3K----
Earning before tax -352.50%-25.2M46.35%-25.69M72.43%-5.57M-74.52%-47.89M-20.2M-272.29%-27.44M-251.47%-17.74M-39.13%15.93M-22.23%11.71M-12.61%26.17M
Tax -407.75%-2.03M-81.11%689K-38.68%658K139.34%3.65M--1.07M121.38%1.52M148.93%2.15M30.01%-7.13M17.08%-4.4M-30.90%-10.18M
After-tax profit from continuing operations -454.37%-27.23M43.48%-25.01M74.32%-4.91M-70.71%-44.24M-19.12M-394.51%-25.92M-313.08%-15.59M-44.94%8.8M-25.03%7.32M-27.88%15.98M
Earning after tax -454.37%-27.23M43.48%-25.01M74.32%-4.91M-70.71%-44.24M-19.12M-394.51%-25.92M-313.08%-15.59M-44.94%8.8M-25.03%7.32M-27.88%15.98M
Minority profit 101.40%11K73.97%-850K71.75%-784K-366.77%-3.27M---2.78M-78.36%1.22M-100.84%-39.78K-57.55%5.66M-35.09%4.71M9.64%13.33M
Profit attributable to shareholders -559.95%-27.24M41.05%-24.16M74.76%-4.13M-50.97%-40.98M-16.35M-963.57%-27.14M-696.80%-15.55M18.28%3.14M4.16%2.61M-73.45%2.66M
Basic earnings per share -568.42%-0.012741.36%-0.011275.00%-0.0019-51.59%-0.0191-0.0076-940.00%-0.0126-700.00%-0.007225.00%0.00150.00%0.0012-74.47%0.0012
Diluted earnings per share -568.42%-0.012741.36%-0.011275.00%-0.0019-51.59%-0.0191-0.0076-940.00%-0.0126-700.00%-0.007225.00%0.00150.00%0.0012-74.47%0.0012
Currency Unit HKDHKDHKDHKDHKDHKDHKDHKDHKDHKD
Accounting Standards HKASHKASHKASHKASHKASHKASHKASHKASHKASHKAS
Audit Opinions --Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion
Auditor --Ernst & Young--Ernst & Young--Ernst & Young--Ernst & Young--Ernst & Young

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
% Chg

No Data